Marksans Pharma Ltd. Acquires 100% Stake in Netherlands-Based QliniQ B.V. to Strengthen European Presence
Marksans Pharma has announced the acquisition of 100% of the share capital of QliniQ B.V., a Dutch pharmaceutical company. This strategic move…